Načítá se...
Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemia
The use of nucleoside analog-based chemoimmunotherapeutic regimens over the last decade has significantly improved outcomes in patients with chronic lymphocytic leukemia (CLL). Nonetheless, virtually all patients with CLL relapse from chemoimmmunotherapy and current available therapies are not curat...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3696187/ https://ncbi.nlm.nih.gov/pubmed/20055657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428190903350405 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|